ginsenoside rh2 has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Lang, Z; Tao, Q; Wang, H; Yu, S; Yu, Z; Zhang, J; Zheng, J; Zheng, L | 1 |
| He, C; Li, T; Shen, B; Wang, F; Zhao, W; Zhou, Y | 1 |
| Chen, ZC; Cheng, JT; Hsu, CT; Lo, SH; Niu, CS; Niu, HS | 1 |
3 other study(ies) available for ginsenoside rh2 and Cirrhosis
| Article | Year |
|---|---|
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11.
Topics: Amino Acid Transport System y+; Ferroptosis; Fibrosis; Hepatic Stellate Cells; Humans; Inflammation; Interferon Regulatory Factor-1; Iron; Liver Cirrhosis | 2023 |
[Ginsenoside Rh2 inhibits renal fibrosis and renal cell apoptosis in rats with diabetic nephropathy by downregulating discoid domain receptor 1].
Topics: Animals; Apoptosis; Diabetes Mellitus; Diabetic Nephropathies; Fibrosis; Ginsenosides; Kidney; Male; Rats; Rats, Sprague-Dawley | 2021 |
Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARĪ“-STAT3 Signaling in Type 1-Like Diabetic Rats.
Topics: Animals; Biomarkers; Blood Glucose; Cardiomyopathies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Drugs, Chinese Herbal; Fibrosis; Gene Expression; Ginsenosides; Heart Function Tests; Male; Myocardium; Myocytes, Cardiac; PPAR delta; Rats; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor | 2017 |